
RIGL Stock Soars: A 41.4% Gain in a Year – Is It Time to Buy or Sell?
Rigel Pharmaceuticals: A Beacon of Hope in the Healthcare Industry 2024 was a remarkable year for Rigel Pharmaceuticals (NASDAQ: RIGL). The biotech company, known for its innovative approach to immunology and oncology research, reported impressive financial results and made significant strides in drug development. As we look forward to 2025, the future seems bright for…